FDA Inspection 1059005 — Ipsen BioPharm Ltd
The FDA completed an inspection of Ipsen BioPharm Ltd on July 6, 2018 in Wrexham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 6, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wrexham (United Kingdom)